Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) : final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- Charles J. Ryan
- , Matthew R. Smith
- , Karim Fizazi
- , Fred Saad
- , Peter F. A. Mulders
- , Cora N. Sternberg
- , Kurt Miller
- , Christopher J. Logothetis
- , Neal D. Shore
- , Eric J. Small
- , Joan Carles. Joan
- , Thomas W. Flaig
- , Mary-Ellen Taplin
- , Celestia S. Higano
- , Paul de Souza
- , Johann S. de Bono
- , Thomas W. Griffin
- , Peter de Porre
- , Margaret K. Yu
- , Youn C. Park
Research output: Contribution to journal › Article › peer-review
1256
Citations
(Scopus)